Private Market View

Kernalbio

Drug Discovery · Cambridge, MA · Founded 2016 · Privately Held (backing)

Last price · $/share
Implied valuation
$110.5M
Total raised
$36.1M
Last round
Later Stage VC (Series A)
Jul 2022
What is Kernalbio worth?
$110.5Mlast known valuation

Kernalbio last raised $25.0M in its Later Stage VC (Series A) (Jul 2022).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 47 names
  • ·Watchlist + deal alerts for Kernalbio
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Jul 2022Later Stage VC (Series A)$25.0M

How Kernalbio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Kernalbio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Kernalbio worth?
Kernalbio's last known valuation is $110.5M.
How much has Kernalbio raised?
Kernalbio has raised $36.1M in total funding across 1 recorded rounds.
When did Kernalbio last raise?
Kernalbio last raised in Jul 2022 (Later Stage VC (Series A)), raising $25.0M.
Kernalbio Valuation 2026 — $110.5M | Private Market View